Arctic Vision to acquire MDCO Technology’s ophthalmic device business

China-based Arctic Vision has signed an agreement for the acquisition of the ophthalmic device business of MDCO Technology.

The transaction will integrate MDCO’s intraocular lens (IOL), implantable contact lens (Phakic Lens), and refractive device platforms into Arctic Vision’s global innovation framework for ophthalmic solutions.

The acquisition is expected to enhance Arctic Vision’s capabilities by combining advanced device engineering and manufacturing from MDCO with its existing research and development (R&D) in therapies.

This integration aligns with Arctic Vision’s strategy to expand its pipeline in areas with significant unmet needs in the ophthalmic sector.

Arctic Vision expects to build a portfolio, leveraging its R&D strengths in retinal, ocular surface, and neuro-ophthalmic areas alongside MDCO’s design and manufacturing expertise.

Following the transaction, MDCO will operate as a wholly owned subsidiary of Arctic Vision.

The combined group will maintain operations in three locations: Shanghai for biopharmaceutical research and regulatory affairs; Hangzhou for device R&D, manufacturing, and commercial management; and California for design and global collaboration.

MDCO specialises in cataract and myopia-correction solutions, leveraging materials-science and precision-moulding expertise developed over nearly two decades. Its Hangzhou site is the centre for operations, manufacturing, R&D, and commercial management.

Arctic Vision founder, chairman and CEO Dr Eddy Wu said: “This transaction represents a pivotal step for Arctic Vision’s long-term growth strategy.

“Through the integration of MDCO’s ophthalmic device platforms with Arctic Vision’s pharmaceutical innovation capabilities, we are establishing a truly comprehensive ophthalmic innovation ecosystem—one that integrates scientific excellence with advanced manufacturing and commercial scale.

“Looking ahead, we are building a company structurally prepared for broader global investment participation and future capital-market opportunities while expanding our ability to reach more patients and deliver greater impact across the ophthalmology community worldwide.”

Unlock up to 35% savings on GlobalData reports

Use the code at checkout in the report store

• 20% OFF

  Buy 2 reports

  Use code:

  Bundle20

• 25% OFF

  Buy 3 reports

  Use code:

  Bundle25

• 30% OFF

  Buy 4 reports

  Use code:

  Bundle30

• 35% OFF

  Buy 5+ reports

  Use code:

  Bundle35

Valid on all reports priced $995 and above. Cannot be combined with other offers.

Still deciding what will work best for your business?

Ask our experts for help.

Enquire before buying